A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. - Wikidata - wikimedia - TriplyDB

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.

http://www.wikidata.org/entity/Q34560319

about

Probiotics for induction of remission in Crohn's disease Probiotics for maintenance of remission in Crohn's disease Responders and non-responders to probiotic interventions: how can we improve the odds?Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients Diet therapy for inflammatory bowel diseases: The established and the new Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials Probiotics in inflammatory bowel diseases and associated conditions Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood Risk and safety of probiotics Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy Gut microbiota, probiotics, and human health Use of probiotics for prevention of radiation-induced diarrhea.Antibiotics and probiotics in treatment of inflammatory bowel disease.Probiotics and prebiotics in chronic inflammatory bowel diseases.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Infectious etiopathogenesis of Crohn's disease Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly-a phase I open label study to assess safety, tolerability and cytokine responses.Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis.Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease.Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism.Probiotic actions on diseases: implications for therapeutic treatments.Probiotics, nuclear receptor signaling, and anti-inflammatory pathways.Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.The gut microbiota and inflammatory bowel disease.Nutraceutical Supplements for Inflammatory Bowel Disease.Gut microbiota and inflammation.Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children.A gastroenterologist's guide to probiotics.Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG.

P2860

Q24242115-F70B0513-4DA0-43A3-A249-AA886504BC4E Q24244110-7944DB06-02AA-4DED-B800-0B28F849D334 Q24594332-E10AB1A0-E0F3-4C74-A305-638129550FA0 Q26750985-318F3C0B-E589-4E70-9FD0-8EDBDDA23470 Q26768564-2A4B6DC1-E3C4-4941-8E13-F8559C95B407 Q26784194-00EBEF0C-2378-41B4-BCF5-493F958A5243 Q26823347-B362E19B-8AD0-414B-AF4F-8A8F2F3E7DC9 Q26995672-2EFB2544-28E6-49D9-B6AD-890B8E349F7D Q27001546-93615D67-04E2-494A-87DE-9571123EECDB Q27002496-DEF1448B-D0A9-4C55-BED4-6FCC949B04DD Q28072437-94DAA6A8-79FB-4AD5-A702-D4762B3A6723 Q28075770-8809DAA2-DFC1-4CD6-8BD1-94642AD3E7E2 Q28087466-77EB3E6E-F67C-41C4-8B79-E5C821A57531 Q28254207-F020A6C5-55E5-43B8-B7D8-3D8A1B239B56 Q33256876-A6D57251-E5CD-4EFA-B135-D79032847F75 Q33503647-E5EB16C2-57E3-4D26-85CE-F50CA1CAF95D Q33666412-EE1410C7-3E9E-4F84-9F58-A4ABDA12615E Q33787744-C6E5A581-D070-4472-ADEE-124D4F6E70A4 Q33867934-C66A0FAE-13DB-4734-BC0A-51DF9889D08F Q34013030-DCA0CD4F-15BF-440D-A09D-888230B3B4EF Q34152778-C002CB3A-CC87-4EEC-999C-4162C7445C89 Q34168490-25F5873D-2EDD-4790-9968-45E126A0EAA8 Q34402709-80EE34F6-C8EE-4802-A7FF-DD03D252775B Q34600094-E99D797A-761E-4CF5-91C4-93FBB74408C3 Q34622749-CE225FAF-F23C-4CFB-921F-B3423B8C749B Q34813567-E67B0F41-AA1C-4CEF-B51A-817D971AEBFD Q35015672-19F5A2AE-AF0E-481D-8020-73C451B316C9 Q35096915-DB281EDA-3A5E-49A6-905D-194E9CC08081 Q35131051-E321DFAE-F8FC-4726-A9CE-BC4EA6D24C30 Q35195891-C32B64AE-386A-4BD9-A23C-EBCE7568F891 Q35228714-5C1B775F-332B-455A-AE76-0210B836E2AE Q35245299-C7E3E6A9-1006-4715-B117-65E000CC249B Q35446516-AC414608-5397-49C5-A1C3-2BB33724FD79 Q35646449-C9AB2BF5-209C-49C5-9124-F4DA7C819527 Q35670894-3434640D-D4C2-44B9-B4C2-92C4B094C8B2 Q35760489-89940184-F06C-476D-845F-2DA60C7A4F6E Q35812927-0289A172-A02F-4815-9136-73B77C1CF7B7 Q35832867-5F563A84-BDCB-46EA-91BD-239630BF04F0 Q36179468-AB02AEA1-E7FF-4EA3-858E-15D48C4029D8 Q36510380-C3A57EB5-DBAB-45ED-82DD-83782E9E4739

P2860

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.

http://www.wikidata.org/entity/Q34560319

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

A randomized, double-blind tri ...... children with Crohn's disease.

@ast

A randomized, double-blind tri ...... children with Crohn's disease.

@en

A randomized, double-blind tri ...... children with Crohn's disease.

@nl

type

label

A randomized, double-blind tri ...... children with Crohn's disease.

@ast

A randomized, double-blind tri ...... children with Crohn's disease.

@en

A randomized, double-blind tri ...... children with Crohn's disease.

@nl

prefLabel

A randomized, double-blind tri ...... children with Crohn's disease.

@ast

A randomized, double-blind tri ...... children with Crohn's disease.

@en

A randomized, double-blind tri ...... children with Crohn's disease.

@nl

P1433

Q34560319-D6EE6A35-A5FB-47D4-9D73-08302E8454C7

P1476

Q34560319-96B3C8F1-3D50-459F-8915-FB6281F1A849

P2093

Q34560319-1109AF50-2292-47B7-8BF2-DF2D7332FBE8

Q34560319-291B8986-29D7-4E59-9979-7216BCED9656

Q34560319-2C0FA3B5-E43F-4CDD-BF0D-538042B3F370

Q34560319-52DF99B6-82B7-41DA-BF88-E3A12C0B71B3

Q34560319-53412E73-BB54-4575-9A08-0DCEC5A9AFD7

Q34560319-6BD3C83C-2793-46D4-A8AF-C7A5461F11A3

Q34560319-A4B54B10-B656-4C0B-8711-07C3AEBDA609

Q34560319-A64D824D-4401-46C8-AFC8-E04392D9152F

Q34560319-B45199A7-B849-4339-911F-95836C4C35F0

Q34560319-BDBE3ABD-F57A-4C63-A979-AA1F24F669B6

P2860

Q34560319-0395883E-F86E-49AD-9D19-6A0D2F8DEC01

Q34560319-0C7F0A65-E894-43A2-8B06-8DDF4C2C20E0

Q34560319-1D8BB96B-6633-4E19-A18A-203BE7D217E4

Q34560319-20CFCB22-9DF5-4DD9-8D7E-B52A955B1B2D

Q34560319-26296223-D50E-4A41-9CC3-B35C740CB2E8

Q34560319-2924153F-7DA7-4A12-8CD9-3D167E4A7D92

Q34560319-2FA785CE-11D8-4D0F-AAF0-3F501983D096

Q34560319-3048C7AA-97EC-453D-9295-7F704C481673

Q34560319-4F5E837F-2613-4A12-9984-5E77C88F0669

Q34560319-537754F6-958F-4AD9-A78D-41DD01D79CB6

P304

Q34560319-E86F0DC4-216A-4418-BB17-95FB93A17504

P31

Q34560319-390D56DE-DA35-4C5C-B953-55FDDFA2F3E9

P356

Q34560319-CF0B53CF-B35D-41BE-A21B-51B2E2680AF8

P433

Q34560319-1B555F4C-86F5-4E1A-A2C9-0EFDD0372415

P478

Q34560319-3D3B05A6-5B37-4A0E-B680-F79EECD44353

P50

Q34560319-6250CAF5-0154-4DFF-B9C2-C36C00FA0C80

P577

Q34560319-DE8DF577-D91F-4903-92AC-6FAB3D924747

P698

Q34560319-689917E0-78C7-41FF-98B1-5014DF3E0C39

P921

Q34560319-3E37153E-1BC1-4474-8B14-C13FE464C0D9

Q34560319-840F68B7-9EA5-4F40-9062-CDA796E61179

P356

01.MIB.0000175905.00212.2C

P1433

Inflammatory Bowel Diseases

P1476

A randomized, double-blind tri ...... children with Crohn's disease.

@en

P2093

Anna Zholudev

http://www.w3.org/2001/XMLSchema#string

Athos Bousvaros

http://www.w3.org/2001/XMLSchema#string

Barry Goldin

http://www.w3.org/2001/XMLSchema#string

Christine Botelho

http://www.w3.org/2001/XMLSchema#string

George D Ferry

http://www.w3.org/2001/XMLSchema#string

Joel R Rosh

http://www.w3.org/2001/XMLSchema#string

Jon A Vanderhoof

http://www.w3.org/2001/XMLSchema#string

Jonathan Evans

http://www.w3.org/2001/XMLSchema#string

Joseph Levy

http://www.w3.org/2001/XMLSchema#string

Karen F Murray

http://www.w3.org/2001/XMLSchema#string

P2860

Lactobacillus GG in inducing and maintaining remission of Crohn's disease

Saccharomyces boulardii in maintenance treatment of Crohn's disease

A pilot trial of Saccharomyces boulardii in ulcerative colitis

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children

Toll-like receptors and innate immunity

Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel.

P304

833-839

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.MIB.0000175905.00212.2C

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Maria Oliva-Hemker

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16116318

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease